Loading stock data…
GoodRx Holdings (GDRX)
$2.96+0.09 (+3.14%)
Market ClosedLast close Jul 24
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
GoodRx Holdings, Inc. in the Healthcare sector is trading at $2.96 with a market capitalization of $916M. Wall Street consensus targets $3.21 (13 analysts), implying a +8.5% move over the next 12 months. The stock is currently 49% below its 52-week high of $5.81, remaining 8.8% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +8.5% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $194.01M↓ | $194.78M↓ | $196.03M↓ | $203.07M | $202.97M |
| Gross Profit | $173.85M↓ | $177.32M↓ | $182.61M↓ | $189.72M | $189.61M |
| Operating Income | $14.01M↓ | $22.68M↑ | $14.62M↓ | $26.81M↑ | $23.38M |
| Net Income | $1.17M↓ | $5.42M↑ | $1.12M↓ | $12.84M↑ | $11.05M |
Peer Comparison
JNJUNHPFE
Fundamentals
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that prov...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$916.12M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.30%
Volume
Today's trading volume
529,504
Recent News
1 Cash-Producing Stock for Long-Term Investors and 2 We Avoid
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
GoodRx (GDRX): Buy, Sell, or Hold Post Q1 Earnings?
GoodRx has had an impressive run over the past six months as its shares have beaten the S&P 500 by 13.1%. The stock now trades at $3.14, marking a 21.5% gain. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
1 Profitable Stock for Long-Term Investors and 2 Facing Challenges
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's
Check out the companies making headlines yesterday:
GoodRx (GDRX) Stock Trades Up, Here Is Why
Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 2.6% in the afternoon session after the company announced a partnership with Paytient, a healthcare affordability solutions provider.